Vivo Capital’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Vivo Capital's PRAX Position: Q3 2026 in Review
Vivo Capital held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 271,116 shares worth $79M. The position accounts for 8.69% of the portfolio, ranked #1.
Vivo Capital first reported a position in PRAX in Q2 2025 and has held it in 6 quarters since. The position peaked at $109M in Q1 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Vivo Capital held 271,116 shares of Praxis Precision Medicines worth $79M as of Q3 2026.
- Vivo Capital left its Praxis Precision Medicines share count unchanged in Q3 2026.
- Praxis Precision Medicines made up 8.69% of Vivo Capital's portfolio in Q3 2026, its #1 holding.
- Vivo Capital first reported a position in Praxis Precision Medicines in Q2 2025 and has held it in 6 quarters since.
- Vivo Capital's Praxis Precision Medicines position peaked at $109M in Q1 2026.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.